Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Minerva Ginecol ; 64(1): 9-14, 2012 Feb.
Artigo em Italiano | MEDLINE | ID: mdl-22334226

RESUMO

AIM: The chronic pelvic pain (CPP) linked to endometriosis, relatively frequent condition in women of reproductive age, often represents the main complaint for which the patient seeks medical advice. The purpose of this prospective study was to evaluate if and to which extent systematic ablation of endometriotic lesions causes an improvement and/or disappearance of pain in patients with ascertained endometriosis and in whom the main preoperative symptom is chronic pelvic pain. METHODS: This study examined 109 patients, affected by chronic pelvic pain secondary to endometriosis, underwent laparoscopic treatment. All patients in the preoperative phase and only the 92 coming back for follow up, were asked both to fill out an anonymous questionnaire about their quality of life and to indicate on a numeric visual analogue scale (VAS) the intensity of the perceived pain. RESULTS: Overall the median of the VAS score for pain decreased from 7.5 before surgery to 2.5 at one-year postoperative-follow up, which was consistent (Wilcoxon test) with a statistically significant regression (P<0.0001) of the intensity of perceived pain (disappearance or marked reduction) in the operated patients, independently from the stage of the disease and the type of pain; also data on quality of life during work and social activity indicated a relevant improvement respectively in 82% and in 83% of patients following the laparoscopic procedure. CONCLUSION: For this reason and as suggested by the present international guidelines, when the medical therapy against pain fails and/or in the presence of an adnexal mass (chocolate cyst) or deep endometriotic lesion, it is generally correct to rely on surgical ablation of the lesions preferably by laparoscopy.


Assuntos
Dor Crônica/cirurgia , Endometriose/cirurgia , Laparoscopia , Dor Pélvica/cirurgia , Adulto , Dor Crônica/etiologia , Endometriose/complicações , Feminino , Humanos , Pessoa de Meia-Idade , Dor Pélvica/etiologia , Estudos Prospectivos , Adulto Jovem
2.
Minerva Ginecol ; 62(6): 501-7, 2010 Dec.
Artigo em Italiano | MEDLINE | ID: mdl-21079571

RESUMO

AIM: Heterogeneity premature ovarian insufficiency (POI) is one of the reasons why there are different causes that contribute in determining this type of hormonal disorder. Although the causes have already been established for many types of premature ovarian failure, are still uncertain causes in most cases of idiopathic forms, despite the description of several candidate genes, including BMP-15 gene. The gene under study is precisely the BMP-15, which is part of the superfamily of Transforming Growth Factors-beta or the TGF-ß, which also belong to the growth differentiation factors (GDFs). METHODS: This study examined a sample of Sicilian women suffering from POI, carefully selected according to their age, since in these cases, the genetic factor probably has a greater impact. RESULTS AND CONCLUSION: Identify a mutant gene that causes ovarian failure may be important to make a diagnosis that can predict the possible future development of the disease. The outcome of the studies, however, has not found the gene in question, but it is hypothesized that this may be a direct consequence of the limited amount of women that was done the study, a case which may be rebutted by increasing the number of patients.


Assuntos
Proteína Morfogenética Óssea 15/genética , Mutação , Polimorfismo Genético , Insuficiência Ovariana Primária/diagnóstico , Insuficiência Ovariana Primária/genética , Adolescente , Adulto , Estudos de Casos e Controles , Feminino , Ligação Genética , Marcadores Genéticos/genética , Predisposição Genética para Doença , Genoma Humano , Humanos , Fator de Crescimento Transformador beta/genética
3.
Bratisl Lek Listy ; 111(8): 443-8, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21033624

RESUMO

Advances researches in the diagnosis and treatment of childhood, adolescent and adult cancer have greatly increased the life expectancy of premenopausal women with cancer. However, one of the serious side effects of these treatments is the risk of damage to fertility. The ovaries are very sensitive to cytotoxic and radiotherapeutic treatment. The only established method of fertility preservation is embryo cryopreservation according to the Ethics Committee of the American Society for Reproductive Medicine (2005), but this option requires the patient to be of pubertal age, have a partner or use donor sperm, and be able to undergo a cycle of ovarian stimulation, which is not possible when the radiotherapy has to be initiated immediately or when stimulation is contraindicated according to the type of cancer. For patients who need immediate radiotherapy, cryopreservation of ovarian tissue is the only possible alternative. This manuscript reports the different techniques of cryopreservation and the results of transplantation of cryopreserved ovarian tissue. The current techniques allow cryopreservation of human ovarian fragments for a long time with good follicular survival rate after thawing. Numerous studies ultimately in this field have demonstrated to improve the survival rate of the oocytes and cryopreserved follicles. Moreover this manuscript includes a case of a 17-year-old girl who had to undergo pelvic irradiation for non-Hodgkin's lymphoma and the laparoscopic treatment to preserve the fertility (Fig. 2, Ref. 47).


Assuntos
Criopreservação , Ovário , Adolescente , Criopreservação/métodos , Feminino , Fertilidade/efeitos da radiação , Humanos , Neoplasias/radioterapia , Ovário/efeitos da radiação , Ovário/transplante , Pelve/efeitos da radiação , Coleta de Tecidos e Órgãos/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA